FINWIRES · TerminalLIVE
FINWIRES

US Natural Gas Update: Futures Tick Higher on Shifting Weather Outlooks, Mixed Demand Signals

By

-- US natural gas futures edged higher in midday trading on Tuesday as updated weather models pointed to a split demand picture, with colder late-season conditions across the Northern US boosting heating demand while warmer forecasts in the South supported cooling load expectations.

The front-month Henry Hub contract rose 0.81% to $2.72 per million British thermal units, while the continuous contract increased 0.04% to $2.55/MMBtu.

NatGasWeather.com said models added several total degree days since last Friday, driven mainly by colder shifts and additional heating degree days. "Weather patterns are not nearly as bearish as they have been, and likely viewed as neutral, if not a touch bullish," the firm said Monday.

The Wall Street Journal reported Tuesday that the colder forecast should limit weekly inventory builds from reaching or exceeding 100 billion cubic feet through the second week of May.

Fundamentals, however, remain loose. Trading Economics noted that elevated spring temperatures have already pushed storage levels to about 8% above seasonal norms. The US Energy Information Administration's last report showed inventories rising by 103 Bcf, well above expectations, last year's 77 Bcf build, and the five-year average increase of 64 Bcf.

On the supply side, NRG Energy said dry gas production has softened slightly over the past week, averaging about 106.3 Bcf per day as gross output edged lower. It added that while production has eased from recent highs, supply remains comfortably above demand.

Trading Economics separately said output has declined about 4.1 Bcf/d over the past 18 days to an 11-week low of 108.1 Bcf/d, as major producers scaled back in response to persistently low prices.

Demand has also weakened with seasonal moderation. NRG Energy said total US consumption averaged near 101.7 Bcf/d over the week, with declines led by residential and commercial usage and only limited offset from power burn.

LNG export feedgas has remained relatively steady, holding in a tight range around 18.8 to 19.0 Bcf/d, according to NRG Energy.

Related Articles

Sectors

Sector Update: Tech Stocks Fall Late Afternoon

Tech stocks fell late Tuesday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) dropping 1.5% and the State Street SPDR S&P Semiconductor ETF (XSD) slumping 4.4%.The Philadelphia Semiconductor index shed 3.3%.In corporate news, OpenAI recently missed its own targets for new users and revenue, the Wall Street Journal reported late Monday, citing people familiar with the matter. Tech bellwether Nvidia (NVDA) fell 1.2%, Broadcom (AVGO) dropped 4.2%, Advanced Micro Devices (AMD) shed 3.1%, Oracle (ORCL) lost 3.6%, and Intel (INTC) declined 1.4%.Lam Research (LRCX), Applied Materials (AMAT) and KLA (KLAC) were among the chip equipment companies believed to have received a letter last week from the US Department of Commerce ordering them to halt certain tool shipments to China's second-largest chipmaker Hua Hong, Reuters reported. Lam declined 3%, Applied Materials dropped 5.1%, and KLA shed 4.1%.Amazon.com (AMZN) plans to make OpenAI's artificial intelligence models available to its customers after Microsoft (MSFT) relinquished its exclusive rights to resell the ChatGPT maker's products, Bloomberg reported Tuesday, citing Amazon Web Services CEO Matt Garman in a Bloomberg Television interview. Amazon shares were down 0.6%, and Microsoft rose 0.6%.Spotify Technology (SPOT) reported stronger-than-expected Q1 profit, but its premium subscriber growth and outlook disappointed investors. The stock fell 12%.

$AMAT$AMD$AMZN$AVGO$INTC$KLAC$LRCX$MSFT$NVDA$ORCL$SPOT
Research

Research Alert: Paccar: Q1 Eps Match Expectations; Class-8 Outlook Reiterated

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PCAR's Q1 results matched consensus with operating EPS of $1.15 vs. $0.96 in the prior year, supported by the absence of litigation charges that impacted Q1 2025. New truck deliveries fell 7K units to 33.1K globally, with North American Class-8 shipments declining while Europe showed strength. The Parts business managed positive expansion despite truck sales softness, benefiting from strategic investments in distribution infrastructure. Management maintained an upbeat tone on customer demand trends, though their North American outlook for retail Class-8 truck sales remained unchanged from Q4. PCAR generated healthy operating cash flow of $972M vs. $910M and maintained a strong balance sheet, in our view. Management projected full-year capex of ~$750M and R&D expenses of ~$475M for next-generation powertrains. We see the unchanged shipment projections as a signal that management is not entirely confident an inflection is occurring stronger than previously anticipated.

$PCAR
Australia

Erasca Shares Fall After Preliminary Phase 1 Dose Escalation Data

Erasca (ERAS) shares fell 48% Tuesday after the company reported preliminary phase 1 dose-escalation data for its experimental ERAS-0015 in patients with RAS-mutant solid tumors, including colorectal cancer, non-small-cell lung cancer and pancreatic adenocarcinoma.The preliminary data, from ongoing trials in the US and China, suggest ERAS-0015 may be combined with standard-of-care doses of panitumumab, positioning it as a potential backbone therapy for future combination regimens, the company said.The therapy was generally "well tolerated," with no dose-limiting toxicities or treatment discontinuations due to adverse events, according to a statement.Erasca said it selected 24 mg and 32 mg once daily as recommended doses for further study and said the drug showed "promising clinical potential" for combination use with panitumumab.In a regulatory filing, the company said a patient, who was a 66 year-old male with heavily pretreated metastatic pancreatic adenocarcinoma, had died. The company said grade 3 treatment-related adverse events of pneumonitis progressed to grade 5 following withdrawal of supportive care per patient decision.Price: $9.96, Change: $-9.20, Percent Change: -48.02%

$ERAS